Near future
No Result
View All Result
25 September 2023
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Transports
  • Spazio
  • AI
  • concepts
  • H+
Understand, anticipate, improve the future.
CES2023 / Coronavirus / Russia-Ukraine
Near future
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Transports
  • Spazio
  • AI
  • concepts
  • H+

Understand, anticipate, improve the future.

No Result
View All Result
Medicine

Breast cancer, vaccine ready in 8 years

A breast cancer vaccine that stimulates the immune system achieves the expected results, awaits the 3rd phase of the trials and will be ready in 8 years.

October 15, 2019
Gianluca RiccioGianluca Riccio
⚪ 2 minutes
Share51Pin5Tweet14SendShare4ShareShare3

READ IN:

Clinical tests of an immunotherapy treatment against breast cancer have shown positive signs and the researchers will take them to the head even more probable in the coming years.

The ability of this therapy is to teach the body to find and kill cancer cells without harming healthy ones. A vaccine for breast cancer (do not forget it: the only amazing breasts are healthy ones. And prevention, I recommend). That's not all, however: even tests on other neoplasms have given positive signals.

For researchers at the Mayo Clinic in Jacksonville, Florida, a vaccine that targets the onset and development of breast and ovarian cancer will be available in less than 10 years.

Scientific evidence shows the total removal of cancer cells in one patient, and another in the remission phase.

"The treatment stimulates the patient's immune response, whose immune cells attack the diseased ones," says Dr. Saranya Chumsri, oncologist of the renowned medical center.

The article continues after the related links

VIR-1388, HIV vaccine being tested in the USA and South Africa

From the laboratory to life: here are the bacteria that "see" tumor DNA

It still takes a while

Before the vaccine is available, authorization will need to be obtained from the FDA to initiate Phase 3 clinical trials. It will take a maximum of 3 years, but the researchers plan to get the green light even sooner.

"It is reasonable to assume that we will have a vaccine by 2027, and it will be available at the pharmacy or from your doctor," says the researcher at Mayo. Keith L. Knutson.

The characteristics of the vaccines

"We know they're healthy," Knutson says. "We know they stimulate the immune system and have a major impact on breast and ovarian cancer. We have seen no adverse effects or irritation. We will now pass our solid arguments based on clinical results to the FDA."

Since the 90s, immunologists have multiplied their efforts to destroy cancer without affecting healthy cells (as happens with chemotherapy and radiotherapy).

Immunotherapy might be the ideal solution, but there are many different types of cancer, over 100, and it's not easy to imagine a vaccine for each one shortly, like the breast cancer vaccine they are developing.

Despite these difficulties, the immune therapy market will grow to 102 billion euros in 2023.

Chumsri and Kutson are aware that it will be difficult to develop a vaccine for any type of cancer, but in the meantime they are happy to have put the first two on the right track.

"The signs are extraordinary," Knutson reiterates. "We are building on this basis".

Tags: cancerbreast cancerMayvaccines

Latest news

  • Minimum wage: a step forward or a leap in the dark for Italy?
  • Solar cars could halve the need for charging
  • The crazy food of the future: from edible clouds to mussel ceramics
  • NASA, recovered the sample from the asteroid Bennu: why it is important
  • Tesla and the new abilities of Optimus robots: "Ready for mass production"
  • EV, goodbye frequent charging: I-State promises over 1.000 km of autonomy.
  • Revolutionary generator transforms humidity into continuous electrical energy
  • All the maps of the future: from research tools to doors to tomorrow
  • The bizarre AI that translates the language of chickens
  • Jeddah Tower, construction site of the one kilometer high skyscraper reopens


GPT Chat Megaeasy!

Concrete guide for those approaching this artificial intelligence tool, also designed for the school world: many examples of applications, usage indications and ready-to-use instructions for training and interrogating Chat GPT.

To submit articles, disclose the results of a research or scientific discoveries write to the editorial staff

Enter the Telegram channel of Futuroprossimo, click here. Or follow us on Instagram, Facebook, Twitter, Mastodon e LinkedIn.

FacebookTwitterInstagramTelegramLinkedInMastodonPinterestTikTok

The daily tomorrow.


Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.

  • Environment
  • Architecture
  • Artificial intelligence
  • Gadgets
  • concepts
  • Design
  • Medicine
  • Spazio
  • Robotica
  • Work
  • Transports
  • Energy
  • Edition Francaise
  • Deutsche Ausgabe
  • Japanese version
  • English Edition
  • Portuguese Edition
  • Read more
  • Spanish edition

Subscribe to our newsletter

  • The Editor
  • Advertising on FP
  • Privacy Policy

© 2023 Near future - Creative Commons License
This work is distributed under license Creative Commons Attribution 4.0 International.

No Result
View All Result
Understand, anticipate, improve the future.
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Transports
  • Spazio
  • AI
  • concepts
  • H+